EWP
LEGN icon

Elevation Wealth Partners’s Legend Biotech LEGN Stock Holding History

Elevation Wealth Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-48
Closed -$1.39K – 1379
2026
Q2 		$1.39K Buy
+48
New +$1.29K ﹤0.01% 1233

Other funds holding LEGN

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

Elevation Wealth Partners's LEGN Position: Q3 2026 in Review

Elevation Wealth Partners sold out of Legend Biotech (LEGN) in Q3 2026, closing a stake of 48 shares — an estimated $1.39K sold.

Elevation Wealth Partners first reported a position in LEGN in Q2 2026 and held it in 1 quarter. The position peaked at $1.39K in Q2 2026. 5 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Elevation Wealth Partners reported no remaining Legend Biotech position as of Q3 2026 after selling out during the quarter.
  • Elevation Wealth Partners sold 48 Legend Biotech shares in Q3 2026, an estimated $1.39K.
  • Elevation Wealth Partners first reported a position in Legend Biotech in Q2 2026 and held it in 1 quarter.
  • Elevation Wealth Partners's Legend Biotech position peaked at $1.39K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.